Multicentre study to assess the performance of an artificial intelligence instrument to support qualitative diagnosis of colorectal polyps

Computer-aided diagnosis (CAD) using artificial intelligence (AI) is expected to support the characterisation of colorectal lesions, which is clinically relevant for efficient colorectal cancer prevention. We conducted this study to assess the diagnostic performance of commercially available CAD sys...

Full description

Saved in:
Bibliographic Details
Published inBMJ open gastroenterology Vol. 11; no. 1; p. e001553
Main Authors Sato, Keigo, Kuramochi, Mizuki, Tsuchiya, Akihiko, Yamaguchi, Akihiro, Hosoda, Yasuo, Yamaguchi, Norio, Nakamura, Naohiro, Itoi, Yuki, Hashimoto, Yu, Kasuga, Kengo, Tanaka, Hirohito, Kuribayashi, Shiko, Takeuchi, Yoji, Uraoka, Toshio
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group 22.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Computer-aided diagnosis (CAD) using artificial intelligence (AI) is expected to support the characterisation of colorectal lesions, which is clinically relevant for efficient colorectal cancer prevention. We conducted this study to assess the diagnostic performance of commercially available CAD systems. This was a multicentre, prospective performance evaluation study. The endoscopist diagnosed polyps using white light imaging, followed by non-magnified blue light imaging (non-mBLI) and mBLI. AI subsequently assessed the lesions using non-mBLI (non-mAI), followed by mBLI (mAI). Eventually, endoscopists made the final diagnosis by integrating the AI diagnosis (AI+endoscopist). The primary endpoint was the accuracy of the AI diagnosis of neoplastic lesions. The diagnostic performance of each modality (sensitivity, specificity and accuracy) and confidence levels were also assessed. Overall, 380 lesions from 139 patients were included in the analysis. The accuracy of non-mAI was 83%, 95% CI (79% to 87%), which was inferior to that of mBLI (89%, 95% CI (85% to 92%)) and mAI (89%, 95% CI (85% to 92%)). The accuracy (95% CI) of diagnosis by expert endoscopists using mAI (91%, 95% CI (87% to 94%)) was comparable to that of expert endoscopists using mBLI (91%, 95% CI (87% to 94%)) but better than that of non-expert endoscopists using mAI (83%, 95% CI (75% to 90%)). The level of confidence in making a correct diagnosis was increased when using magnification and AI. The diagnostic performance of mAI for differentiating colonic lesions is comparable to that of endoscopists, regardless of their experience. However, it can be affected by the use of magnification as well as the endoscopists' level of experience.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
We received research funding from Fujifilm Japan. There are no other conflicts of interest.
Additional supplemental material is published online only. To view, please visit the journal online (https://doi.org/10.1136/bmjgast-2024-001553).
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
ISSN:2054-4774
2054-4774
DOI:10.1136/bmjgast-2024-001553